NLS Pharma

Switzerland
Unterägeri, Zug, Switzerland, CH-6370

Company profile

NLS Pharma company profile

NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia. Its patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.

Business identity

Contact email
[email protected]
Phone number
+41 41 618 80 00
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
CH-6370
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
11
Total equity funding
$38.1M
Last funding
Post IPO Debt / $25M / 2025-03-31
Last equity funding
Post IPO Equity / $7M
Investors
2
Lead investors
2
Founders
3
Articles
44
Exited on
2021-01-29

Founders and investors

Founders

Alex ZwyerBruno FigadèreEric Konofal

Lead investors

Biotechnology Value FundYorkville Advisors

Investors

Biotechnology Value FundYorkville Advisors